Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Journal of Cardiology|May 2, 2025
Impact of FFR-CT before coronary angiography on the management of non-culprit lesions among high-risk NSTE-ACS patientsAurelia Zimmerli, David Meier, Adil Salihu, et al.
Annals of Biomedical Engineering|September 21, 2023
Blood Flow Energy Identifies Coronary Lesions Culprit of Future Myocardial InfarctionMaurizio Lodi Rizzini, Alessandro Candreva, Valentina Mazzi, et al.
The American Journal of Cardiology|December 8, 2016
Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting StentsKonstantinos C Koskinas, Masanori Taniwaki, Fabio Rigamonti, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 9, 2021
Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III studyFranz R Eberli, Hans-Peter Stoll, Philip Urban, et al.
The New England Journal of Medicine|August 18, 2005
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularizationStephan Windecker, Andrea Remondino, Franz R Eberli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 29, 2021
Future culprit detection based on angiography-derived FFRMattia Pagnoni, David Meier, Alessandro Candreva, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 4, 2017
Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trialsSalvatore Cassese, Robert A Byrne, Peter Jüni, et al.
Journal of the American College of Cardiology|September 18, 2007
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trialMario Togni, Stéphanie Eber, Jeannette Widmer, et al.
Pageof 20